WEBSITECHANGES

Website Changes

---

06/04/2010

ImmunoCellular Therapeutics` ICT-107 Demonstrates 80 Percent Survival at 2 Years in Phase I Study of Newly Diagnosed Glioblastoma Patients

---

05/26/2010

Rell Signs Oral Chemotherapy Bill

---

05/25/2010

Treatment disparities following the diagnosis of an astrocytoma.

---

05/22/2010

Lack of Efficacy of Bevacizumab Plus Irinotecan in Children With Recurrent Malignant Glioma and Diffuse Brainstem Glioma: A Pediatric Brain Tumor Consortium Study.

---

05/22/2010

DCA research on brain cancer

---

05/22/2010

Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in glioblastoma patients treated with temozolomide: a phase II study.

---

05/22/2010

Dichloroacetate not yet an effective treatment for aggressive brain cancer

---

05/18/2010

IBTA E-News May 2010

---

05/18/2010

Outsmarting Brain Tumors: A Conference for Patients, Families and Caregivers

---

05/18/2010

Updated Survivor Story Peter D. a 16 year GBM survivor!

---

05/17/2010

Perils in evidence based madicine

---

05/13/2010

AACR: Targeted Agent Boosts Survival in Brain Cancer

---

05/13/2010

Generic drug shows promise for brain tumour treatment, study shows

---

05/11/2010

THE SAME BRAIN TUMOR TISSUE THAT TAKES LIVES, CAN BE USED TO SAVE THEM

---

05/08/2010

Continuous low-dose temozolomide and celecoxib in recurrent glioblastoma. /h3>

---

05/08/2010

Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma.

---

05/06/2010

Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma.

---

05/06/2010

Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma.

---

04/29/2010

`Landmark` cancer vaccine gets FDA approval (Editor`s Note: this is for Prostate Cancer, but I am sending it because it is the first cancer vaccine to get approval. Hopefully making it easier to get brain tumor vaccines approved!]

---

04/28/2010

Patient Trial of Personalized Two-Drug Therapy for Brain Tumors Launched

---

04/28/2010

The diagnosis of brain tumours in children: a guideline to assist healthcare professionals in the assessment of children who may have a brain tumour.

---

04/26/2010

Celtic Pharma Announces Preclinical Findings that XERECEPT(R) Potentiates Significantly the Tumor Inhibition Activity of Avastin(R)

---

04/26/2010

Comment: "5th Annual BTO Lacrosse Classic" to Support Local Pediatric Brain Tumor Foundation

---

04/26/2010

Celtic Pharma Announces Initiation of Pediatric Dose Tolerance Trial Evaluating XERECEPT(R) in Pediatric Patients with Primary and Metastatic Brain Tumors

---

04/23/2010

Cetuximab, bevacizumab, and irinotecan for patients with primary glioblastoma and progression after radiation therapy and temozolomide: a phase II trial.

---